Lymphoma Archives

B-Cell Lymphomas: AIDS-Related B-Cell Lymphoma

November 19, 2021

View a treatment regimen chart for AIDS-related B-cell lymphoma, with detailed information based on condition (ie, Burkitt lyphoma, Castleman’s Disease).

doctor reviewing patient chart at hospital bedside

Lymphoma

Excess Risk of CVD Low With Radiotherapy After Chemotherapy for Early-Stage Hodgkin Lymphoma

By

Jennifer Larson

November 19, 2021

Researchers sought to determine the potential risk of cardiovascular mortality vs risk of disease recurrence in patients with early-stage HL receiving IFRT after ABVD.

Lymphoma

MRD Assessment Can Guide Treatment Discontinuation in CLL/SLL

By

Sucharita Mistry, PhD

November 9, 2021

Stopping treatment after induction did not impact disease-free survival in patients with undetectable minimal residual disease.

Lymphoma

Brentuximab Vedotin Provides ‘Robust Clinical Benefit’ in Cutaneous T-Cell Lymphoma

By

Sucharita Mistry, PhD

November 1, 2021

Time to next treatment was significantly longer with brentuximab vedotin.

Lymphoma

Effect of Bundle Nursing on Thrombosis Risk in Patients With Non-Hodgkin Lymphoma

By

Jessica Nye, PhD

October 18, 2021

A single-institution study determined the effect of a novel nursing practice on incidence of PICC-UEDVT, outcomes, and satisfaction with care in patients with NHL.

Clinical Charts

B-Cell Lymphomas: Diffuse Large B-Cell Lymphoma

October 7, 2021

Access detailed treatment regimens for diffuse large B-cell lymphoma, such as R-CHOP with RT and radiotherapy.

ASCO QCS 2021

Cancer Treatment Toxicity Successfully Monitored Via Smartphone App

By

Jessica Nye, PhD

October 1, 2021

Researchers report on their implementation of a mobile-health tool for monitoring symptoms of treatment toxicity.

ASCO QCS 2021

Trends in Use of Anti-Infective Prophylaxis With Non-Hodgkin Lymphoma Treatment

By

Jessica Nye, PhD

September 30, 2021

A review of data from a large database demonstrated limited use of anti-infective prophylaxis in patients with non-Hodgkin lymphoma across US community settings nationwide.